Patentability Of Frontline Plus Formulation Claims Confirmed



Published:

Merial announced today the United States Patent and Trademark Office reconfirmed the patentability of formulation claims covering Merial’s Frontline Plus, a flea and tick control product.

“The ultimate result is that we expect some of the products infringing the formulation claims to be removed from the market.” says Judy Jarecki-Black, PhD, Esq., head of intellectual property with Merial, an animal health pharmaceutical company.

Additional information regarding companies involved with potential formulation infringement and actionable steps was expected to be released later this week, according to earlier information from a public relations representative. The release of the additional information is now expeted in coming weeks, according to Merial.

“We are pleased that the patent office confirmed the patentability of Merial’s inventions directed at fipronil and (S)-methoprene containing spot-on compositions,” Dr. Jarecki-Black says. “Merial is also pursuing litigation against other manufacturers in cases where it believes its patents have been violated. We plan to continue to vigorously defend our patent rights and continue our strong support of the veterinary profession.”

<Home>

Edit Module
Edit ModuleShow Tags

Archive »Read More

Abaxis Enjoys Huge Jump in Sales, Profit

Partnering with distributors paid off for Abaxis, while competitor Idexx saw a small revenue dip while moving to direct sales.

Tag Maker PetHub Adds Patient Records Feature

A hospital’s electronic records may be shared to help identity lost pets wearing a PetHub tag.

Do You Know a Hero Vet or Vet Tech?

The American Humane Association is accepting nominations until March 13 as part of a nationwide contest.

Add your comment:
Edit Module
Edit ModuleEdit ModuleShow Tags Edit Module
Edit Module Edit Module
Edit ModuleShow Tags

Events


Show More...
Edit Module
Edit Module